• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Health Catalyst Announces CEO Dan Burton to Step Down to Pursue Service Opportunities

    8/7/25 4:38:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology
    Get the next $HCAT alert in real time by email

    Mr. Burton to Retire June 30, 2026, Actively Committed to Support Board in Transition and New CEO Search

    SALT LAKE CITY, Aug. 7, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Health Catalyst Chief Executive Officer Dan Burton is stepping down from his role as CEO, effective June 2026, to enable additional time to pursue a few volunteer service opportunities he and his wife will participate in, in support of their faith, as active members of the Church of Jesus Christ of Latter-Day Saints.

    (PRNewsfoto/Health Catalyst)

    As a result, Mr. Burton will transition from his full-time position as CEO, effective June 30, 2026, and retire from his full-time work at Health Catalyst. Mr. Burton will support the Board in its search for a new CEO and will continue to serve on the Board. 

    By then, Mr. Burton will have been leading Health Catalyst full-time for 15 years, having joined at an early stage as both an investor and an advisor, when the company consisted of just three team members, in January 2011. He initially planned to serve as interim CEO for only a period of several months. His subsequent, longstanding tenure, as requested by the Board, led to the company's meaningful expansion, including filing for an initial public offering in 2019, growing to include 1,100 active healthcare clients and over 1,400 team members, publishing over 375 documented client case studies of data-driven healthcare improvement, and enabling more than $2.2 billion in client-approved, measurable improvements.

    Mr. Burton's leadership is centered on serving others and a strong commitment to the company's mission. This resulted in Health Catalyst maintaining exceptionally high team member engagement levels, which have consistently ranked between the 94th and 99th percentile during the past decade, according to Gallup assessments. As a result of this focus on team member engagement, Health Catalyst has earned more than 125 Best Workplace Awards since 2013. The company has been recognized by esteemed organizations locally in Utah, nationally, and internationally, including accolades from Inc., FORTUNE, Newsweek, Modern Healthcare, Glassdoor, and U.S. News & World Report, among others.

    It is this servant leadership mindset that also informs Mr. Burton's desire to become more deeply involved with his faith. For many years, Mr. Burton and his wife, Sarah, have planned to pursue mission-oriented service opportunities that align with their faith, after Dan completed his tenure as CEO and their children became adults.

    "It has been the highlight of my career to serve in this role, in a company filled with teammates I love, in service of a mission that I believe in, in support of clients who are so deeply committed to that same mission, and with the backing of our shareholders, past and present, who have enabled us to pursue this mission to make healthcare measurably better," Mr. Burton said. "During this transition, I remain deeply committed to strong execution, every day, in support of accomplishing our company's goals and objectives, including driving client and shareholder value."

    Jack Kane, Chairman of the Health Catalyst Board of Directors, said, "We, as a Board, would like to thank Dan for his many years of outstanding service to the company in the role of CEO. We are grateful Dan will continue to serve on the Board. Our Nominating and Corporate Governance Committee will conduct a CEO search to identify an effective, world-class CEO to lead Health Catalyst in its next chapter."

    This is the third time a member of Health Catalyst's Senior Leadership Team has stepped down from Health Catalyst to provide additional faith-based volunteer service for the Church of Jesus Christ of Latter-Day Saints. In 2023, Health Catalyst's Chief Operating Officer, Paul Horstmeier, was called to serve for three years as the Mission President of the Puerto Rico San Juan Mission. From 2017 to 2020, Health Catalyst Co-Founder Steve Barlow was called to serve as a Mission President in Ecuador.

    Health Catalyst, as a mission-driven organization, is grateful for and supportive of the many contributions its team members make in providing various types of volunteer service to the broader community.

    About Health Catalyst

    Health Catalyst (NASDAQ:HCAT) is a leading provider of data and analytics technology and services that ignite smarter healthcare, lighting the path to measurable clinical, financial, and operational improvement. More than 1,000 organizations worldwide rely on Health Catalyst's offerings, including our cloud-based technology ecosystem, Health Catalyst Ignite™, AI-enabled data and analytics solutions, and expert services to drive meaningful outcomes across hundreds of millions of patient records. Powered by high-value data, standardized measures and registries, and deep healthcare domain expertise, Ignite helps organizations transform complex information into actionable insights. Backed by a multi-decade mission and a proven track record of delivering billions of dollars in measurable results, Health Catalyst continues to serve as the catalyst for massive, data-informed healthcare improvement and innovation.

    Media Contact:

    Kathryn Mykleseth

    PR and Communications Director

    [email protected]

    Investor Relations Contact:

    Jack Knight

    Vice President, Investor Relations

    +1 (855) 309-6800

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/health-catalyst-announces-ceo-dan-burton-to-step-down-to-pursue-service-opportunities-302524823.html

    SOURCE Health Catalyst

    Get the next $HCAT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HCAT

    DatePrice TargetRatingAnalyst
    8/11/2025Buy → Neutral
    Citigroup
    8/8/2025$4.00Overweight → Neutral
    Cantor Fitzgerald
    6/17/2025Buy → Neutral
    BTIG Research
    4/9/2025Outperform → In-line
    Evercore ISI
    1/8/2025$9.00Sector Weight → Overweight
    KeyBanc Capital Markets
    4/10/2024Overweight → Sector Weight
    KeyBanc Capital Markets
    1/3/2024$14.00Overweight
    Barclays
    1/3/2024$11.00In-line → Outperform
    Evercore ISI
    More analyst ratings

    $HCAT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Health Catalyst Announces CEO Dan Burton to Step Down to Pursue Service Opportunities

    Mr. Burton to Retire June 30, 2026, Actively Committed to Support Board in Transition and New CEO Search SALT LAKE CITY, Aug. 7, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Health Catalyst Chief Executive Officer Dan Burton is stepping down from his role as CEO, effective June 2026, to enable additional time to pursue a few volunteer service opportunities he and his wife will participate in, in support of their faith, as active members of the Church of Jesus Christ of Latter-Day Saints.

    8/7/25 4:38:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Reports Second Quarter 2025 Results

    SALT LAKE CITY, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2025. "For the second quarter of 2025, I am pleased by our strong financial results, including total revenue of $80.7 million and Adjusted EBITDA of $9.3 million, with these results beating our quarterly guidance on each metric." said Dan Burton, CEO of Health Catalyst. "I also want to share my plan to retire from the CEO role at Health Catalyst effective June 30, 2026. By then, I will have been leading Health Catalyst full-time

    8/7/25 4:03:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst to Announce Second Quarter 2025 Operating Results and Host Conference Call on Thursday, August 7, 2025

    SALT LAKE CITY, July 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its second quarter 2025 operating results on Thursday, August 7, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ225." A live audio webcast will be available online at https://ir.healthcatalyst.com/.

    7/17/25 8:30:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Burton Daniel D. bought $204,525 worth of shares (26,200 units at $7.81), increasing direct ownership by 2% to 1,172,623 units (SEC Form 4)

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    2/27/24 4:01:39 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    SEC Filings

    View All

    SEC Form 10-Q filed by Health Catalyst Inc

    10-Q - Health Catalyst, Inc. (0001636422) (Filer)

    8/8/25 4:13:06 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

    8-K - Health Catalyst, Inc. (0001636422) (Filer)

    8/7/25 4:11:16 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Health Catalyst, Inc. (0001636422) (Filer)

    7/10/25 5:26:18 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Health Catalyst downgraded by Citigroup

    Citigroup downgraded Health Catalyst from Buy to Neutral

    8/11/25 9:56:17 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst downgraded by Cantor Fitzgerald with a new price target

    Cantor Fitzgerald downgraded Health Catalyst from Overweight to Neutral and set a new price target of $4.00

    8/8/25 8:19:52 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst downgraded by BTIG Research

    BTIG Research downgraded Health Catalyst from Buy to Neutral

    6/17/25 7:47:53 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Smith S. Dawn was granted 36,231 shares, increasing direct ownership by 55% to 101,692 units (SEC Form 4)

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    7/11/25 4:01:06 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Director Gallagher Duncan was granted 36,231 shares, increasing direct ownership by 47% to 113,282 units (SEC Form 4)

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    7/10/25 8:17:34 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Director Hoggard Green Jill was granted 36,231 shares, increasing direct ownership by 131% to 63,937 units (SEC Form 4)

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    7/10/25 8:17:24 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Leadership Updates

    Live Leadership Updates

    View All

    Ardent Health Appoints Robert DeMichiei to Board of Directors

    Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U

    4/3/25 5:27:00 PM ET
    $AP
    $ARDT
    $HCAT
    Fluid Controls
    Industrials
    Hospital/Nursing Management
    Health Care

    Modern Health Welcomes Adam Brown as Chief Financial Officer

    Strengthens Executive Team with Seasoned Healthcare Finance Leader Modern Health, a leading global workplace mental health platform, today announces the appointment of Adam Brown as Chief Financial Officer. With an extensive background in healthcare finance and operations, including significant experience scaling high-growth healthcare technology companies, Brown brings deep industry expertise to the company. "Adam is a valued addition to Modern Health's leadership team, and we are thrilled to welcome him on board. His impressive track record and deep understanding of both public and private markets strengthens our executive bench as we continue to execute our vision," said Gyre Renwick

    1/15/25 10:16:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Signs Definitive Agreement to Acquire Upfront Healthcare Services

    SALT LAKE CITY, Jan. 13, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has signed a definitive agreement to acquire Upfront Healthcare Services, Inc. ("Upfront"), a next-generation patient engagement platform provider. Health Catalyst anticipates the acquisition will close in the first quarter of 2025.Upfront provides a market-leading patient activation and engagement platform and a proprietary strategic marketing analytics and content personalization solution for healthcare enterprises. Upfront's automated patient acquisition and retention solu

    1/13/25 8:00:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Financials

    Live finance-specific insights

    View All

    Health Catalyst Reports Second Quarter 2025 Results

    SALT LAKE CITY, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2025. "For the second quarter of 2025, I am pleased by our strong financial results, including total revenue of $80.7 million and Adjusted EBITDA of $9.3 million, with these results beating our quarterly guidance on each metric." said Dan Burton, CEO of Health Catalyst. "I also want to share my plan to retire from the CEO role at Health Catalyst effective June 30, 2026. By then, I will have been leading Health Catalyst full-time

    8/7/25 4:03:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst to Announce Second Quarter 2025 Operating Results and Host Conference Call on Thursday, August 7, 2025

    SALT LAKE CITY, July 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its second quarter 2025 operating results on Thursday, August 7, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ225." A live audio webcast will be available online at https://ir.healthcatalyst.com/.

    7/17/25 8:30:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Reports First Quarter 2025 Results

    SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2025. "For the first quarter of 2025, I am pleased by our strong financial results, including total revenue of $79.4 million and Adjusted EBITDA of $6.3 million, with these results beating our quarterly guidance on each metric," said Dan Burton, CEO of Health Catalyst. "Additionally, we are happy to share that we added 10 net new Platform Clients in Q1 2025. This is especially encouraging given that Q1 is typically a quieter bo

    5/7/25 4:03:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Health Catalyst Inc

    SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)

    11/14/24 7:51:57 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    SEC Form SC 13G filed by Health Catalyst Inc

    SC 13G - Health Catalyst, Inc. (0001636422) (Subject)

    11/14/24 4:44:34 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by Health Catalyst Inc

    SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)

    11/12/24 3:55:05 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology